Amersham is about visualising life at all levels within the human body - from organs, tissues and cells, to the molecules and biochemicals that make our genetic structure. Our businesses are focused on enabling molecular medicine, with the aim of bringing new discoveries about the molecular basis of disease into clinical practice in the diagnosis and treatment of disease.

Our medical diagnostics business, Amersham Health, is a leading pharmaceutical provider of diagnostic and predictive imaging products and services, specialising in the field of in vivo diagnostic products for the early and accurate detection of disease. We focus on the management of heart disease, circulatory disease and stroke; degeneration of the brain such as is seen in Alzheimer's disease and Parkinson's disease; and a range of cancers. In addition, we are a major provider of therapy products to treat prostate, thyroid and other cancers.

Our life sciences business, Amersham Biosciences, is a leading global provider of integrated systems and solutions (instruments, reagents, software) for disease research and drug discovery, development and manufacture. Amersham Biosciences comprises two business areas, discovery systems and protein separations. In discovery systems, we provide high throughput systems to help researchers in industry and academia understand the genetic and molecular basis of disease and speed up their drug development. In protein separations, we provide research and manufacturing technologies that enable pharmaceutical and biotech companies to bring new biological drugs to the market.